Ulthera, Inc. develops novel therapeutic medical devices for the expanding aesthetic, cosmetic surgery and dermatology markets. These markets are defined by consumers wishing to improve their appearance by correcting congenital or acquired benign skin pathologies or to reverse the natural effects of aging. The company is targeting the non-invasive face lift and facial rejuvenation market segment, which will exceed $4 B worldwide in 2010.